BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7996543)

  • 1. Synthesis and molecular modeling of 1-phenyl-1,2,3,4-tetrahydroisoquinolines and related 5,6,8,9-tetrahydro-13bH-dibenzo[a,h]quinolizines as D1 dopamine antagonists.
    Minor DL; Wyrick SD; Charifson PS; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1994 Dec; 37(25):4317-28. PubMed ID: 7996543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 9-Dihydroxy-2,3,7,11b-tetrahydro-1H-naph[1,2,3-de]isoquinoline: a potent full dopamine D1 agonist containing a rigid-beta-phenyldopamine pharmacophore.
    Ghosh D; Snyder SE; Watts VJ; Mailman RB; Nichols DE
    J Med Chem; 1996 Jan; 39(2):549-55. PubMed ID: 8558526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and pharmacological characterization of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as dopamine receptor ligands.
    Charifson PS; Wyrick SD; Hoffman AJ; Simmons RM; Bowen JP; McDougald DL; Mailman RB
    J Med Chem; 1988 Oct; 31(10):1941-6. PubMed ID: 3050089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (+/-)-3-[4'-(N,N-dimethylamino)cinnamyl]benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Kline RH; Geter-Douglass B; Izenwasser S; Witkin JM; Newman AH
    J Med Chem; 1996 Aug; 39(17):3423-8. PubMed ID: 8765528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conformational analysis and molecular modeling of 1-phenyl-, 4-phenyl-, and 1-benzyl-1,2,3,4-tetrahydroisoquinolines as D1 dopamine receptor ligands.
    Charifson PS; Bowen JP; Wyrick SD; Hoffman AJ; Cory M; McPhail AT; Mailman RB
    J Med Chem; 1989 Sep; 32(9):2050-8. PubMed ID: 2527994
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding and preliminary evaluation of 5-hydroxy- and 10-hydroxy-2,3, 12,12a-tetrahydro-1H-[1]benzoxepino[2,3,4-ij]isoquinolines as dopamine receptor ligands.
    Claudi F; Di Stefano A; Napolitani F; Cingolani GM; Giorgioni G; Fontenla JA; Montenegro GY; Rivas ME; Rosa E; Michelotto B; Orlando G; Brunetti L
    J Med Chem; 2000 Feb; 43(4):599-608. PubMed ID: 10691686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CoMFA-based prediction of agonist affinities at recombinant D1 vs D2 dopamine receptors.
    Wilcox RE; Tseng T; Brusniak MY; Ginsburg B; Pearlman RS; Teeter M; DuRand C; Starr S; Neve KA
    J Med Chem; 1998 Oct; 41(22):4385-99. PubMed ID: 9784114
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of a series of substituted benzo[a]phenanthridines as agonists at D1 and D2 dopamine receptors.
    Knoerzer TA; Watts VJ; Nichols DE; Mailman RB
    J Med Chem; 1995 Aug; 38(16):3062-70. PubMed ID: 7636869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and receptor affinities of some conformationally restricted analogues of the dopamine D1 selective ligand (5R)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl- 1H-3-benzazepin-7-ol.
    Berger JG; Chang WK; Clader JW; Hou D; Chipkin RE; McPhail AT
    J Med Chem; 1989 Aug; 32(8):1913-21. PubMed ID: 2666667
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational analysis of D1 dopamine receptor agonists: pharmacophore assessment and receptor mapping.
    Mottola DM; Laiter S; Watts VJ; Tropsha A; Wyrick SD; Nichols DE; Mailman RB
    J Med Chem; 1996 Jan; 39(1):285-96. PubMed ID: 8568818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. (+/-)-(N-alkylamino)benzazepine analogs: novel dopamine D1 receptor antagonists.
    Shah JH; Izenwasser S; Geter-Douglass B; Witkin JM; Newman AH
    J Med Chem; 1995 Oct; 38(21):4284-93. PubMed ID: 7473556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic benzo[a]phenanthridines: resolution and pharmacological evaluation of the enantiomers of dihydrexidine, the full efficacy D1 dopamine receptor agonist.
    Knoerzer TA; Nichols DE; Brewster WK; Watts VJ; Mottola D; Mailman RB
    J Med Chem; 1994 Jul; 37(15):2453-60. PubMed ID: 7914538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, conformation, and dopaminergic activity of 5,6-ethano-bridged derivatives of selective dopaminergic 3-benzazepines.
    Weinstock J; Oh HJ; DeBrosse CW; Eggleston DS; Wise M; Flaim KE; Gessner GW; Sawyer JL; Kaiser C
    J Med Chem; 1987 Aug; 30(8):1303-8. PubMed ID: 2886663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further definition of the D1 dopamine receptor pharmacophore: synthesis of trans-6,6a,7,8,9,13b-hexahydro-5H-benzo[d]naphth[2,1-b]azepines as rigid analogues of beta-phenyldopamine.
    Negash K; Nichols DE; Watts VJ; Mailman RB
    J Med Chem; 1997 Jul; 40(14):2140-7. PubMed ID: 9216832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dihydrexidine, a novel full efficacy D1 dopamine receptor agonist.
    Mottola DM; Brewster WK; Cook LL; Nichols DE; Mailman RB
    J Pharmacol Exp Ther; 1992 Jul; 262(1):383-93. PubMed ID: 1352553
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and pharmacological evaluation of substituted naphth[1,2,3-de]isoquinolines (dinapsoline analogues) as D1 and D2 dopamine receptor ligands.
    Qandil AM; Lewis MM; Jassen A; Leonard SK; Mailman RB; Nichols DE
    Bioorg Med Chem; 2003 Apr; 11(7):1451-64. PubMed ID: 12628671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. D2 receptor antagonists do not modify guanine nucleotide-sensitive interactions between dopamine and D1 dopamine receptors under in vitro conditions.
    Farrell CB; Lawlor M; Dunne A; O'Boyle KM
    J Neurochem; 1995 Sep; 65(3):1124-30. PubMed ID: 7643090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (+/-)-3-Allyl-6-bromo-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3- benzazepin, a new high-affinity D1 dopamine receptor ligand: synthesis and structure-activity relationship.
    Neumeyer JL; Baindur N; Niznik HB; Guan HC; Seeman P
    J Med Chem; 1991 Dec; 34(12):3366-71. PubMed ID: 1684995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-2,3-dihydroxy-6a,7,8,12b-tetrahydro-6H-chromeno[3,4-c]isoquinoline: synthesis, resolution, and preliminary pharmacological characterization of a new dopamine D1 receptor full agonist.
    Cueva JP; Giorgioni G; Grubbs RA; Chemel BR; Watts VJ; Nichols DE
    J Med Chem; 2006 Nov; 49(23):6848-57. PubMed ID: 17154515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GTP regulation of (-)-stepholidine binding to R(H) of D1 dopamine receptors in calf striatum.
    Dong ZJ; Chen LJ; Jin GZ; Creese I
    Biochem Pharmacol; 1997 Jul; 54(2):227-32. PubMed ID: 9271326
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.